# Perioperative Treatment With Zoledronic Acid in Patients With Resectable Pancreas Cancer

> **NCT00892242** · PHASE1 · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 24 (actual)

## Conditions studied

- Adenocarcinoma

## Interventions

- **DRUG:** Zoledronic acid

## Key facts

- **NCT ID:** NCT00892242
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-12
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** Principal Investigator decided to close the study early.
- **Last updated:** 2014-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00892242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00892242, "Perioperative Treatment With Zoledronic Acid in Patients With Resectable Pancreas Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00892242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*